Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight ...
FDA Drug Recall #D-0074-2023 — Class III — November 14, 2022
Recall Summary
| Recall Number | D-0074-2023 |
| Classification | Class III — Low risk |
| Date Initiated | November 14, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Acella Pharmaceuticals, LLC |
| Location | Alpharetta, GA |
| Product Type | Drugs |
| Quantity | 528 cartons |
Product Description
Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60
Reason for Recall
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Distribution Pattern
USA Nationwide
Lot / Code Information
Lot#: 21084, 21085, Exp 06/30/2023
Other Recalls from Acella Pharmaceuticals, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0014-2026 | Class II | Doxycycline Hyclate Tablets, USP 100 mg*, 500-c... | Sep 29, 2025 |
| D-0490-2024 | Class III | Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, ... | Apr 24, 2024 |
| D-0070-2023 | Class III | Phenytoin Sodium Injection, USP, 250 mg/5 mL, N... | Nov 14, 2022 |
| D-0069-2023 | Class III | Phenytoin Sodium Injection, USP 100 mg/2 mL, ND... | Nov 14, 2022 |
| D-0398-2021 | Class I | NP Thyroid 90 Thyroid Tablets, USP 1&1/2 grain ... | Apr 29, 2021 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.